Features of Patients With CNS Recurrence
Neurologic symptoms at recurrence | |
Coma | 1 |
Seizures | 1 |
Mental status changes, lethargy, confusion | 10 |
Headache | 7 |
Cranial nerve palsy | 7 |
Peripheral sensory or motor symptoms | 5 |
Gait and balance | 2 |
Lumbar puncture | |
Not done | 2 |
Negative | 1 |
Lymphoma cells | 19 |
Other abnormalities/no lymphoma cells | 2 |
Radiologic findings | |
Leptomeningeal involvement | 7 |
Brain parenchymal involvement | 8 |
Negative radiologic studies | 7 |
No radiologic studies | 3 |
Status of systemic disease | |
Simultaneous CNS and systemic relapse | 5 |
Systemic relapse with 40-180 days after CNS relapse | 7 |
Death within 40 days after CNS recurrence without systemic restaging | 7 |
Survival beyond 40 days after CNS recurrence, no systemic recurrence | 5 |
Neurologic symptoms at recurrence | |
Coma | 1 |
Seizures | 1 |
Mental status changes, lethargy, confusion | 10 |
Headache | 7 |
Cranial nerve palsy | 7 |
Peripheral sensory or motor symptoms | 5 |
Gait and balance | 2 |
Lumbar puncture | |
Not done | 2 |
Negative | 1 |
Lymphoma cells | 19 |
Other abnormalities/no lymphoma cells | 2 |
Radiologic findings | |
Leptomeningeal involvement | 7 |
Brain parenchymal involvement | 8 |
Negative radiologic studies | 7 |
No radiologic studies | 3 |
Status of systemic disease | |
Simultaneous CNS and systemic relapse | 5 |
Systemic relapse with 40-180 days after CNS relapse | 7 |
Death within 40 days after CNS recurrence without systemic restaging | 7 |
Survival beyond 40 days after CNS recurrence, no systemic recurrence | 5 |